Epistra

Documentation

Epistra Accelerate

AI-Powered Experimental Condition Optimization Software for Life Sciences

Latest version: v2.0.7 · Commercial software · Product page →

Technical Overview

Epistra Accelerate is an experimental condition optimization software based on Bayesian optimization. It uses a Gaussian Process (GP) as its surrogate model to predict experimental outcomes and quantify uncertainty, enabling the discovery of optimal conditions with significantly fewer trials than conventional methods in high-dimensional and high-cost parameter spaces typical of life science experiments. The optimization algorithms have been designed on benchmark problems that recapitulate real-world life science experimental tasks such as cell culture media optimization.

Key Features

  • Proprietary optimization algorithms specialized for life sciences
  • Multi-objective optimization across quality, cost, and productivity
  • Visualization and interpretation tools for experimental results

Input / Output

Input

  • Historical experimental data (table of conditions and results)
  • Optimization settings (objective variables, search ranges, etc.)

Output

  • Table of recommended experimental conditions for the next round

Performance Benchmarks

Validated results from industry collaborations:

Application Metric Result
Novel assay system construction R&D timeline 44% reduction
Cell preservation reagent development Reagent performance 133% improvement
Biopharmaceutical media development Raw material cost 70% reduction

Version History

Version Summary
2.0.7 Enhanced constraint handling, design space estimation, and cost estimation features
2.0.0 Major refactoring and solver performance update
1.5.1 Initial release (shipped with Shimadzu CellTune v1)

Citation

If you use Epistra Accelerate in your research, please cite as follows:

@misc{epistra_accelerate,
  title  = {Epistra Accelerate},
  author = {Epistra Inc.},
  year   = {2024},
  url    = {https://epistra.jp/epistra-accelerate/docs},
  note   = {version 2.0.7, Accessed: YYYY-MM-DD}
}

Related Publications

Contact

Epistra Inc.

Website: epistra.jp

Inquiries: epistra.jp/contact